- Country: USA
- Summary: Lab reagents for molecular biology
- UST Ref No: 118544066
- Deadline: 14 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: NERP1301246278
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
STATEMENT OF WORK
The Centralized Laboratory Department of the U.S. Naval Medical and Research Unit SOUTH (NAMRU SOUTH) is seeking to purchase laboratory reagents and supplies to be used for the molecular diagnosis of influenza virus, adenovirus, Metapneumovirus, Enterovirus, Rhinovirus, Respiratory Syncytial Virus, Mayaro, dengue, Chikungunya, Zika, and SARS-CoV-2 virus. Specifically, this requirement involves PCR enzymes for reverse transcription, real-time platforms and Illumina that are used in the detection of human influenza viruses (Influenza A-matrix gene and B) and its subtypes (H3, H1pdm/SwH1N1, H1 seasonal and H5) (SOP N6-VIR-MB RV 014); sequencing full genome of influenza A using random amplification and pathogen discovery protocols in Illumina platform; detecting genetic material of Adenovirus in nasal and pharyngeal swab specimens (SOP N6-VIR-MB RV 007); detecting the genetic material of Metapneumovirus (MPV), Enterovirus, Rhinovirus and Respiratory Syncytial Virus in nasal and pharyngeal swabs specimens using a reverse transcription (N6-VIR-MB RV 006); and, amplification of the whole genome of the influenza A virus based on the amplification of full-length gene segments for SNP genotyping, gene expression analysis and genotype (N6-VIR-MB RV 001) and pathogen discovery in respiratory and serum samples collected in our surveillance protocols.
All these NAMRU SOUTH assays have been validated using the TaqMan 7500/7500 Fast Real time PCR system and MiSeq and MiniSeq Illumina platform and therefore, compatibility of the consumables is a requirement. The RT-PCR assays have been developed independently for each SOP and involve much time and effort by laboratory technicians, and supervisors for final approval. Reagents used must remain the same as the ones indicated in the SOPs, otherwise the design and validation of these processes would have to start from scratch, which would delay all processing and the timely diagnosis of... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLab reagents for molecular biology - USA Tender
The DEPT OF DEFENSE | DEPT OF THE NAVY, a Government sector organization in USA, has announced a new tender for Lab reagents for molecular biology. This tender is published on USARFP under UST Ref No: 118544066 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-14.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
